Branched-chain amino acids differentially affect proliferation, glucose-lactate metabolism and BCKDHA expression in human lung and pancreatic cancer cells
DOI:
https://doi.org/10.56782/pps.1050Keywords:
branched-chain amino acids, BCKDHA, cancer cell metabolism, glycolysis, amino acid catabolismAbstract
Branched-chain amino acids (BCAA) are increasingly discussed in the context of cancer metabolism and nutritional support, yet their effects on tumor cells remain insufficiently understood. This study determined how increased concentrations of leucine, isoleucine and valine affect proliferation, glucose–lactate metabolism, extracellular BCAA dynamics and BCKDHA expression in human lung (A549) and pancreatic (MIA PaCa-2) cancer cells and normal keratinocytes (HaCaT). Cells were cultured with individual BCAA or their mixtures at 1.5- and 2-fold higher concentrations than standard medium. Lower BCAA excess, particularly leucine, stimulated proliferation in both cancer cell lines, whereas higher concentrations, especially mixtures of all three amino acids, reduced cancer cell growth. A549 cells showed higher glucose consumption and lactate production than MIA PaCa-2 cells, indicating a more glycolytic phenotype, while pancreatic cancer cells displayed a distinct metabolic pattern despite comparable proliferation. Extracellular amino acid analysis revealed cell type-dependent differences in BCAA utilization, with A549 cells showing the highest depletion. Cancer cells generally exhibited lower BCKDHA expression than keratinocytes, suggesting reduced oxidative utilization of BCAA. These findings indicate that the biological effects of BCAA depend on concentration, composition and tumor type, and suggest that BCAA may support either anabolic or oxidative metabolic pathways depending on cellular context.
Downloads
References
1. Li, F.; Simon, M.C. Cancer Cells Don’t Live Alone: Metabolic Communication within Tumor Microenvironments. Dev. Cell 2020, 54, 183–195. DOI: 10.1016/j.devcel.2020.06.018 DOI: https://doi.org/10.1016/j.devcel.2020.06.018
2. Hanahan, D.; Weinberg, R.A. Hallmarks of Cancer: The next Generation. Cell 2011, 144, 646–674. DOI: 10.1016/j.cell.2011.02.013 DOI: https://doi.org/10.1016/j.cell.2011.02.013
3. Pavlova, N.N.; Thompson, C.B. The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016, 23, 27–47. DOI: 10.1016/j.cmet.2015.12.006 DOI: https://doi.org/10.1016/j.cmet.2015.12.006
4. Kordes, M.; Larsson, L.; Engstrand, L.; Löhr, J.-M. Pancreatic Cancer Cachexia: Three Dimensions of a Complex Syndrome. Br. J. Cancer 2021, 124, 1623–1636. DOI: 10.1038/s41416-021-01301-4 DOI: https://doi.org/10.1038/s41416-021-01301-4
5. Morita-Tanaka, S.; Yamada, T.; Takayama, K. The Landscape of Cancer Cachexia in Advanced Non-Small Cell Lung Cancer: A Narrative Review. Transl. Lung Cancer Res. 2023, 12, 168–180. DOI: 10.21037/tlcr-22-561 DOI: https://doi.org/10.21037/tlcr-22-561
6. Naser, F.J.; Jackstadt, M.M.; Fowle-Grider, R.; Spalding, J.L.; Cho, K.; Stancliffe, E.; Doonan, S.R.; Kramer, E.T.; Yao, L.; Krasnick, B.; et al. Isotope Tracing in Adult Zebrafish Reveals Alanine Cycling between Melanoma and Liver. Cell Metab. 2021, 33, 1493-1504.e5. DOI: 10.1016/j.cmet.2021.04.014 DOI: https://doi.org/10.1016/j.cmet.2021.04.014
7. Mayers, J.R.; Wu, C.; Clish, C.B.; Kraft, P.; Torrence, M.E.; Fiske, B.P.; Yuan, C.; Bao, Y.; Townsend, M.K.; Tworoger, S.S.; et al. Elevation of Circulating Branched-Chain Amino Acids Is an Early Event in Human Pancreatic Adenocarcinoma Development. Nat. Med. 2014, 20, 1193–1198. DOI: 10.1038/nm.3686 DOI: https://doi.org/10.1038/nm.3686
8. Mann, G.; Mora, S.; Madu, G.; Adegoke, O.A.J. Branched-Chain Amino Acids: Catabolism in Skeletal Muscle and Implications for Muscle and Whole-Body Metabolism. Front. Physiol. 2021, 12, Art. No: 702826. DOI: 10.3389/fphys.2021.702826 DOI: https://doi.org/10.3389/fphys.2021.702826
9. Lynch, C.J.; Adams, S.H. Branched-Chain Amino Acids in Metabolic Signalling and Insulin Resistance. Nat. Rev. Endocrinol. 2014, 10, 723–736. DOI: 10.1038/nrendo.2014.171 DOI: https://doi.org/10.1038/nrendo.2014.171
10. Kurmi, K.; Haigis, M.C. Nitrogen Metabolism in Cancer and Immunity. Trends Cell Biol. 2020, 30, 408–424. DOI: 10.1016/j.tcb.2020.02.005 DOI: https://doi.org/10.1016/j.tcb.2020.02.005
11. Nicklin, P.; Bergman, P.; Zhang, B.; Triantafellow, E.; Wang, H.; Nyfeler, B.; Yang, H.; Hild, M.; Kung, C.; Wilson, C.; et al. Bidirectional Transport of Amino Acids Regulates MTOR and Autophagy. Cell 2009, 136, 521–534. DOI: 10.1016/j.cell.2008.11.044 DOI: https://doi.org/10.1016/j.cell.2008.11.044
12. Harris, R.A.; Joshi, M.; Jeoung, N.H.; Obayashi, M. Overview of the Molecular and Biochemical Basis of Branched-Chain Amino Acid Catabolism. J. Nutr. 2005, 135, 1527S-1530S. DOI: 10.1093/jn/135.6.1527S DOI: https://doi.org/10.1093/jn/135.6.1527S
13. Sivanand, S.; Vander Heiden, M.G. Emerging Roles for Branched-Chain Amino Acid Metabolism in Cancer. Cancer Cell 2020, 37, 147–156. DOI: 10.1016/j.ccell.2019.12.011 DOI: https://doi.org/10.1016/j.ccell.2019.12.011
14. Xu, Y.; Yu, W.; Yang, T.; Zhang, M.; Liang, C.; Cai, X.; Shao, Q. Overexpression of BCAT1 Is a Prognostic Marker in Gastric Cancer. Hum. Pathol. 2018, 75, 41–46. DOI: 10.1016/j.humpath.2018.02.003 DOI: https://doi.org/10.1016/j.humpath.2018.02.003
15. Shu, X.; Zhan, P.-P.; Sun, L.-X.; Yu, L.; Liu, J.; Sun, L.-C.; Yang, Z.-H.; Ran, Y.-L.; Sun, Y.-M. BCAT1 Activates PI3K/AKT/MTOR Pathway and Contributes to the Angiogenesis and Tumorigenicity of Gastric Cancer. Front. Cell Dev. Biol. 2021, 9, Art. No: 659260. DOI: 10.3389/fcell.2021.659260 DOI: https://doi.org/10.3389/fcell.2021.659260
16. Tönjes, M.; Barbus, S.; Park, Y.J.; Wang, W.; Schlotter, M.; Lindroth, A.M.; Pleier, S. V; Bai, A.H.C.; Karra, D.; Piro, R.M.; et al. BCAT1 Promotes Cell Proliferation through Amino Acid Catabolism in Gliomas Carrying Wild-Type IDH1. Nat. Med. 2013, 19, 901–908. DOI: 10.1038/nm.3217 DOI: https://doi.org/10.1038/nm.3217
17. Li, J.-T.; Li, K.-Y.; Su, Y.; Shen, Y.; Lei, M.-Z.; Zhang, F.; Yin, M.; Chen, Z.-J.; Wen, W.-Y.; Hu, W.-G.; et al. Diet High in Branched-Chain Amino Acid Promotes PDAC Development by USP1-Mediated BCAT2 Stabilization. Natl. Sci. Rev. 2022, 9, Art. No: nwab212. DOI: 10.1093/nsr/nwab212 DOI: https://doi.org/10.1093/nsr/nwab212
18. Li, J.-T.; Yin, M.; Wang, D.; Wang, J.; Lei, M.-Z.; Zhang, Y.; Liu, Y.; Zhang, L.; Zou, S.-W.; Hu, L.-P.; et al. BCAT2-Mediated BCAA Catabolism Is Critical for Development of Pancreatic Ductal Adenocarcinoma. Nat. Cell Biol. 2020, 22, 167–174. DOI: 10.1038/s41556-019-0455-6 DOI: https://doi.org/10.1038/s41556-019-0455-6
19. Zhang, L.; Han, J. Branched-Chain Amino Acid Transaminase 1 (BCAT1) Promotes the Growth of Breast Cancer Cells through Improving MTOR-Mediated Mitochondrial Biogenesis and Function. Biochem. Biophys. Res. Commun. 2017, 486, 224–231. DOI: 10.1016/j.bbrc.2017.02.101 DOI: https://doi.org/10.1016/j.bbrc.2017.02.101
20. Hattori, A.; Tsunoda, M.; Konuma, T.; Kobayashi, M.; Nagy, T.; Glushka, J.; Tayyari, F.; McSkimming, D.; Kannan, N.; Tojo, A.; et al. Cancer Progression by Reprogrammed BCAA Metabolism in Myeloid Leukaemia. Nature 2017, 545, 500–504. DOI: 10.1038/nature22314 DOI: https://doi.org/10.1038/nature22314
21. Neinast, M.; Murashige, D.; Arany, Z. Branched Chain Amino Acids. Annu. Rev. Physiol. 2019, 81, 139–164. DOI: 10.1146/annurev-physiol-020518-114455 DOI: https://doi.org/10.1146/annurev-physiol-020518-114455
22. Hagenfeldt, L.; Eriksson, S.; Wahren, J. Influence of Leucine on Arterial Concentrations and Regional Exchange of Amino Acids in Healthy Subjects. Clin. Sci. (Lond). 1980, 59, 173–181. DOI: 10.1042/cs0590173 DOI: https://doi.org/10.1042/cs0590173
23. Eriksson, S.; Hagenfeldt, L.; Wahren, J. A Comparison of the Effects of Intravenous Infusion of Individual Branched-Chain Amino Acids on Blood Amino Acid Levels in Man. Clin. Sci. (Lond). 1981, 60, 95–100. DOI: 10.1042/cs0600095 DOI: https://doi.org/10.1042/cs0600095
24. Peng, H.; Wang, Y.; Luo, W. Multifaceted Role of Branched-Chain Amino Acid Metabolism in Cancer. Oncogene 2020, 39, 6747–6756. DOI: 10.1038/s41388-020-01480-z DOI: https://doi.org/10.1038/s41388-020-01480-z
25. Ericksen, R.E.; Lim, S.L.; McDonnell, E.; Shuen, W.H.; Vadiveloo, M.; White, P.J.; Ding, Z.; Kwok, R.; Lee, P.; Radda, G.K.; et al. Loss of BCAA Catabolism during Carcinogenesis Enhances MTORC1 Activity and Promotes Tumor Development and Progression. Cell Metab. 2019, 29, 1151-1165.e6. DOI: 10.1016/j.cmet.2018.12.020 DOI: https://doi.org/10.1016/j.cmet.2018.12.020
26. Saxton, R.A.; Sabatini, D.M. MTOR Signaling in Growth, Metabolism, and Disease. Cell 2017, 168, 960–976. DOI: 10.1016/j.cell.2017.02.004 DOI: https://doi.org/10.1016/j.cell.2017.02.004
27. Wolfson, R.L.; Chantranupong, L.; Saxton, R.A.; Shen, K.; Scaria, S.M.; Cantor, J.R.; Sabatini, D.M. Sestrin2 Is a Leucine Sensor for the MTORC1 Pathway. Science 2016, 351, 43–48. DOI: 10.1126/science.aab2674 DOI: https://doi.org/10.1126/science.aab2674
28. Nie, C.; He, T.; Zhang, W.; Zhang, G.; Ma, X. Branched Chain Amino Acids: Beyond Nutrition Metabolism. Int. J. Mol. Sci. 2018, 19(4), Art. No: 954. DOI: 10.3390/ijms19040954 DOI: https://doi.org/10.3390/ijms19040954
29. Bidgood, C.L.; Philp, L.K.; Rockstroh, A.; Lehman, M.; Nelson, C.C.; Sadowski, M.C.; Gunter, J.H. Targeting Valine Catabolism to Inhibit Metabolic Reprogramming in Prostate Cancer. Cell Death Dis. 2024, 15, Art. No: 513. DOI: 10.1038/s41419-024-06893-2 DOI: https://doi.org/10.1038/s41419-024-06893-2
30. Katagiri, R.; Goto, A.; Nakagawa, T.; Nishiumi, S.; Kobayashi, T.; Hidaka, A.; Budhathoki, S.; Yamaji, T.; Sawada, N.; Shimazu, T.; et al. Increased Levels of Branched-Chain Amino Acid Associated With Increased Risk of Pancreatic Cancer in a Prospective Case-Control Study of a Large Cohort. Gastroenterology 2018, 155, 1474-1482.e1. DOI: 10.1053/J.GASTRO.2018.07.033 DOI: https://doi.org/10.1053/j.gastro.2018.07.033
31. Mohamed, A.; Deng, X.; Khuri, F.R.; Owonikoko, T.K. Altered Glutamine Metabolism and Therapeutic Opportunities for Lung Cancer. Clin. Lung Cancer 2014, 15, 7–15. DOI: 10.1016/j.cllc.2013.09.001 DOI: https://doi.org/10.1016/j.cllc.2013.09.001
32. Yuneva, M.O.; Fan, T.W.M.; Allen, T.D.; Higashi, R.M.; Ferraris, D. V; Tsukamoto, T.; Matés, J.M.; Alonso, F.J.; Wang, C.; Seo, Y.; et al. The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Type. Cell Metab. 2012, 15, 157–170. DOI: 10.1016/j.cmet.2011.12.015 DOI: https://doi.org/10.1016/j.cmet.2011.12.015
33. Vander Heiden, M.G.; Cantley, L.C.; Thompson, C.B. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation. Science 2009, 324, 1029–1033. DOI: 10.1126/science.1160809 DOI: https://doi.org/10.1126/science.1160809
34. Liberti, M. V; Locasale, J.W. The Warburg Effect: How Does It Benefit Cancer Cells? Trends Biochem. Sci. 2016, 41, 211–218. DOI: 10.1016/j.tibs.2015.12.001 DOI: https://doi.org/10.1016/j.tibs.2015.12.001
35. Kamphorst, J.J.; Nofal, M.; Commisso, C.; Hackett, S.R.; Lu, W.; Grabocka, E.; Vander Heiden, M.G.; Miller, G.; Drebin, J.A.; Bar-Sagi, D.; et al. Human Pancreatic Cancer Tumors Are Nutrient Poor and Tumor Cells Actively Scavenge Extracellular Protein. Cancer Res. 2015, 75, 544–553. DOI: 10.1158/0008-5472.CAN-14-2211 DOI: https://doi.org/10.1158/0008-5472.CAN-14-2211
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Julian Chrzanowski, Wojciech Graboń, Sebastian Granica, Miłosz Ludwinek, Aleksandra Zdanowicz, Beata Pyrzyńska, Marta Struga, Agnieszka Cudnoch-Jędrzejewska

This work is licensed under a Creative Commons Attribution 4.0 International License.
For all articles published in Prospects in Pharmaceutical Sciences copyright is retained by the authors. The journal publishes articles in the Open Access policy, within the CC BY 4.0 licence.
This is a human-readable summary of (and not a substitute for) the license. Disclaimer.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.